Biologics and Biosimilars Market Size and Analysis Report 2023-2028

Report Overview:
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
The Global Biologics and Biosimilars Market Size was estimated at USD 191681.38 million in 2021 and is projected to reach USD 271518.20 million by 2028, exhibiting a CAGR of 5.02% during the forecast period.
This report provides a deep insight into the global Biologics and Biosimilars market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics and Biosimilars Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics and Biosimilars market in any manner.
Global Biologics and Biosimilars Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company
•Roche
•Amgen
•AbbVie
•Sanofi-Aventis
•Johnson & Johnson
•Pfizer
•Novo Nordisk
•Eli Lilly
•Novartis
•Merck
•3sbio
•Changchun High Tech
•CP Guojian
•Biotech
•Gelgen
•Innovent
•Dong Bao
•Ganlee
•United Laboratories

Market Segmentation (by Type)
•Monoclonal Antibodies
•Interferon
•Erythropoietin
•Insulin
•Vaccines
•Others

Market Segmentation (by Application)
•Tumor
•Diabetes
•Cardiovascular
•Hemophilia

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Biologics and Biosimilars Market
• Overview of the regional outlook of the Biologics and Biosimilars Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline:
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics and Biosimilars Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

FAQ

The Biologics and Biosimilars market research report includes specific segments by region (country), i.e. North America, Europe, Asia Pacific, South America, Middle East and Africa

The Biologics and Biosimilars market report provides global companies with an opportunity to enter new markets, invest in new sectors, analyze consumer reactions, investigate global competition, and ultimately make smart investments.

Biologics and Biosimilars report covers the latest market developments in terms of acquisitions, growth strategies, joint ventures and collaborations, new product launches, and more on industry.

We can provide customization on reports prior to the sale. If you need customization we request you to provide specific details on customization prior to the dispatch. This is because we move fast with your queries as it requires a lot of diligence. There will be additional charges for customization once the report is dispatched to you and will be treated as post-sales query.

Requesting a Sample copy of the report from Xcellent Insights is hassle-free! You can either request it from the report page or call our sales Executive at US: +1 408 627 7717 /UK: +44 208 638 6439 and share/discuss your requirements. Our Team will share the sample copy of the report with you within 12 Working Hours / Shortly.

Ordering a report from Xcellent Insights is hassle-free! You can select a licence type that suits your requirement and proceed to checkout. It will redirect you to the payment gateway with a list of payment options. Be rest assured that we do not store the payment details. Once we receive the payment, a confirmation email will be sent on your registered mail id with details on the report delivery timeline. You can also get your order placed through our business development executives and they will guide you thoroughly.

You should buy this report from Xcellent Insights for a better clarity on market scenarios.
The market report has been prepared using a pragmatic approach to suit your needs.
We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
Besides, customization is a value-added service if you decide to opt.

TABLE OF CONTENTS
1 Research Methodology and Statistical Scope 1
1.1 Market Definition and Statistical Scope of Biologics and Biosimilars 1
1.2 Key Market Segments 1
1.2.1 Biologics and Biosimilars Segment by Type 1
1.2.2 Biologics and Biosimilars Segment by Application 2
1.3 Methodology & Sources of Information 3
1.3.1 Research Methodology 3
1.3.2 Research Process 4
1.3.3 Market Breakdown and Data Triangulation 5
1.3.4 Base Year 5
1.3.5 Report Assumptions & Caveats 6
2 Biologics and Biosimilars Market Overview 8
2.1 Global Market Overview 8
2.1.1 Global Biologics and Biosimilars Market Size (M USD) Estimates and Forecasts (2017-2028) 8
2.1.2 Global Biologics and Biosimilars Sales Estimates and Forecasts (2017-2028) 9
2.2 Market Segment Executive Summary 9
2.3 Global Market Size by Region 11
3 Biologics and Biosimilars Market Competitive Landscape 13
3.1 Global Biologics and Biosimilars Sales by Manufacturers (2017-2022) 13
3.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2017-2022) 15
3.3 Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 16
3.4 Global Biologics and Biosimilars Average Price by Manufacturers (2017-2022) 17
3.5 Manufacturers Biologics and Biosimilars Sales Sites, Area Served, Product Type 18
3.6 Biologics and Biosimilars Market Competitive Situation and Trends 19
3.6.1 Biologics and Biosimilars Market Concentration Rate 19
3.6.2 Global 5 and 10 Largest Biologics and Biosimilars Players Market Share by Revenue 21
3.6.3 Mergers & Acquisitions, Expansion 21
4 Biologics and Biosimilars Industry Chain Analysis 22
4.1 Biologics and Biosimilars Industry Chain Analysis 22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 22
4.3 Midstream Market Analysis 23
4.4 Downstream Customer Analysis 23
5 The Development and Dynamics of Biologics and Biosimilars Market 25
5.1 Key Development Trends 25
5.2 Driving Factors 25
5.3 Market Challenges 25
5.4 Market Restraints 26
5.5 Industry News 26
5.5.1 New Product Developments 26
5.5.2 Mergers & Acquisitions 26
5.5.3 Expansions 26
5.5.4 Collaboration/Supply Contracts 26
5.6 Industry Policies 26
6 Biologics and Biosimilars Market Segmentation by Type 27
6.1 Evaluation Matrix of Segment Market Development Potential (Type) 27
6.2 Global Biologics and Biosimilars Sales Market Share by Type (2017-2022) 28
6.3 Global Biologics and Biosimilars Market Size Market Share by Type (2017-2022) 29
6.4 Global Biologics and Biosimilars Price by Type (2017-2022) 30
7 Biologics and Biosimilars Market Segmentation by Application 31
7.1 Evaluation Matrix of Segment Market Development Potential (Application) 31
7.2 Global Biologics and Biosimilars Market Sales by Application (2017-2022) 32
7.3 Global Biologics and Biosimilars Market Size (M USD) by Application (2017-2022) 33
7.4 Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022) 34
8 Biologics and Biosimilars Market Segmentation by Region 35
8.1 Global Biologics and Biosimilars Sales by Region 35
8.1.1 Global Biologics and Biosimilars Sales by Region 35
8.1.2 Global Biologics and Biosimilars Sales Market Share by Region 35
8.2 North America 36
8.2.1 North America Biologics and Biosimilars Sales by Country 36
8.2.2 U.S. 37
8.2.3 Canada 37
8.2.4 Mexico 37
8.3 Europe 37
8.3.1 Europe Biologics and Biosimilars Sales by Country 38
8.3.2 Germany 38
8.3.3 France 38
8.3.4 U.K. 38
8.3.5 Italy 39
8.3.6 Russia 39
8.4 Asia Pacific 39
8.4.1 Asia Pacific Biologics and Biosimilars Sales by Region 39
8.4.2 China 40
8.4.3 Japan 40
8.4.4 South Korea 40
8.4.5 India 40
8.4.6 Southeast Asia 40
8.5 South America 40
8.5.1 South America Biologics and Biosimilars Sales by Country 41
8.5.2 Brazil 41
8.5.3 Argentina 41
8.5.4 Columbia 41
8.6 Middle East and Africa 41
8.6.1 Middle East and Africa Biologics and Biosimilars Sales by Region 42
8.6.2 Saudi Arabia 42
8.6.3 UAE 42
8.6.4 Egypt 42
8.6.5 Nigeria 43
8.6.6 South Africa 43
9 Key Companies Profiled 44
9.1 Roche 44
9.1.1 Roche Biologics and Biosimilars Basic Information 44
9.1.2 Roche Biologics and Biosimilars Product Overview 44
9.1.3 Roche Biologics and Biosimilars Product Market Performance 44
9.1.4 Roche Business Overview 45
9.1.5 Roche Biologics and Biosimilars SWOT Analysis 45
9.1.6 Roche Recent Developments 45
9.2 Amgen 46
9.2.1 Amgen Biologics and Biosimilars Basic Information 46
9.2.2 Amgen Biologics and Biosimilars Product Overview 46
9.2.3 Amgen Biologics and Biosimilars Product Market Performance 46
9.2.4 Amgen Business Overview 47
9.2.5 Amgen Biologics and Biosimilars SWOT Analysis 47
9.2.6 Amgen Recent Developments 47
9.3 AbbVie 47
9.3.1 AbbVie Biologics and Biosimilars Basic Information 47
9.3.2 AbbVie Biologics and Biosimilars Product Overview 48
9.3.3 AbbVie Biologics and Biosimilars Product Market Performance 48
9.3.4 AbbVie Business Overview 48
9.3.5 AbbVie Biologics and Biosimilars SWOT Analysis 49
9.3.6 AbbVie Recent Developments 49
9.4 Sanofi-Aventis 49
9.4.1 Sanofi-Aventis Biologics and Biosimilars Basic Information 49
9.4.2 Sanofi-Aventis Biologics and Biosimilars Product Overview 50
9.4.3 Sanofi-Aventis Biologics and Biosimilars Product Market Performance 50
9.4.4 Sanofi-Aventis Business Overview 50
9.4.5 Sanofi-Aventis Biologics and Biosimilars SWOT Analysis 50
9.4.6 Sanofi-Aventis Recent Developments 51
9.5 Johnson & Johnson 51
9.5.1 Johnson & Johnson Biologics and Biosimilars Basic Information 51
9.5.2 Johnson & Johnson Biologics and Biosimilars Product Overview 51
9.5.3 Johnson & Johnson Biologics and Biosimilars Product Market Performance 52
9.5.4 Johnson & Johnson Business Overview 52
9.5.5 Johnson & Johnson Biologics and Biosimilars SWOT Analysis 52
9.5.6 Johnson & Johnson Recent Developments 52
9.6 Pfizer 53
9.6.1 Pfizer Biologics and Biosimilars Basic Information 53
9.6.2 Pfizer Biologics and Biosimilars Product Overview 53
9.6.3 Pfizer Biologics and Biosimilars Product Market Performance 53
9.6.4 Pfizer Business Overview 54
9.6.5 Pfizer Recent Developments 54
9.7 Novo Nordisk 54
9.7.1 Novo Nordisk Biologics and Biosimilars Basic Information 54
9.7.2 Novo Nordisk Biologics and Biosimilars Product Overview 55
9.7.3 Novo Nordisk Biologics and Biosimilars Product Market Performance 55
9.7.4 Novo Nordisk Business Overview 55
9.7.5 Novo Nordisk Recent Developments 55
9.8 Eli Lilly 56
9.8.1 Eli Lilly Biologics and Biosimilars Basic Information 56
9.8.2 Eli Lilly Biologics and Biosimilars Product Overview 56
9.8.3 Eli Lilly Biologics and Biosimilars Product Market Performance 56
9.8.4 Eli Lilly Business Overview 57
9.8.5 Eli Lilly Recent Developments 57
9.9 Novartis 57
9.9.1 Novartis Biologics and Biosimilars Basic Information 57
9.9.2 Novartis Biologics and Biosimilars Product Overview 58
9.9.3 Novartis Biologics and Biosimilars Product Market Performance 58
9.9.4 Novartis Business Overview 58
9.9.5 Novartis Recent Developments 58
9.10 Merck 59
9.10.1 Merck Biologics and Biosimilars Basic Information 59
9.10.2 Merck Biologics and Biosimilars Product Overview 59
9.10.3 Merck Biologics and Biosimilars Product Market Performance 59
9.10.4 Merck Business Overview 60
9.10.5 Merck Recent Developments 60
9.11 3sbio 60
9.11.1 3sbio Biologics and Biosimilars Basic Information 60
9.11.2 3sbio Biologics and Biosimilars Product Overview 61
9.11.3 3sbio Biologics and Biosimilars Product Market Performance 61
9.11.4 3sbio Business Overview 61
9.11.5 3sbio Recent Developments 61
9.12 Changchun High Tech 62
9.12.1 Changchun High Tech Biologics and Biosimilars Basic Information 62
9.12.2 Changchun High Tech Biologics and Biosimilars Product Overview 62
9.12.3 Changchun High Tech Biologics and Biosimilars Product Market Performance 62
9.12.4 Changchun High Tech Business Overview 63
9.12.5 Changchun High Tech Recent Developments 63
9.13 CP Guojian 63
9.13.1 CP Guojian Biologics and Biosimilars Basic Information 63
9.13.2 CP Guojian Biologics and Biosimilars Product Overview 64
9.13.3 CP Guojian Biologics and Biosimilars Product Market Performance 64
9.13.4 CP Guojian Business Overview 64
9.13.5 CP Guojian Recent Developments 64
9.14 Biotech 65
9.14.1 Biotech Biologics and Biosimilars Basic Information 65
9.14.2 Biotech Biologics and Biosimilars Product Overview 65
9.14.3 Biotech Biologics and Biosimilars Product Market Performance 65
9.14.4 Biotech Business Overview 66
9.14.5 Biotech Recent Developments 66
9.15 Gelgen 66
9.15.1 Gelgen Biologics and Biosimilars Basic Information 66
9.15.2 Gelgen Biologics and Biosimilars Product Overview 67
9.15.3 Gelgen Biologics and Biosimilars Product Market Performance 67
9.15.4 Gelgen Business Overview 67
9.15.5 Gelgen Recent Developments 67
9.16 Innovent 68
9.16.1 Innovent Biologics and Biosimilars Basic Information 68
9.16.2 Innovent Biologics and Biosimilars Product Overview 68
9.16.3 Innovent Biologics and Biosimilars Product Market Performance 68
9.16.4 Innovent Business Overview 69
9.16.5 Innovent Recent Developments 69
9.17 Dong Bao 69
9.17.1 Dong Bao Biologics and Biosimilars Basic Information 69
9.17.2 Dong Bao Biologics and Biosimilars Product Overview 70
9.17.3 Dong Bao Biologics and Biosimilars Product Market Performance 70
9.17.4 Dong Bao Business Overview 70
9.17.5 Dong Bao Recent Developments 70
9.18 Ganlee 71
9.18.1 Ganlee Biologics and Biosimilars Basic Information 71
9.18.2 Ganlee Biologics and Biosimilars Product Overview 71
9.18.3 Ganlee Biologics and Biosimilars Product Market Performance 71
9.18.4 Ganlee Business Overview 72
9.18.5 Ganlee Recent Developments 72
9.19 United Laboratories 72
9.19.1 United Laboratories Biologics and Biosimilars Basic Information 72
9.19.2 United Laboratories Biologics and Biosimilars Product Overview 73
9.19.3 United Laboratories Biologics and Biosimilars Product Market Performance 73
9.19.4 United Laboratories Business Overview 73
9.19.5 United Laboratories Recent Developments 73
10 Biologics and Biosimilars Market Forecast by Region 106
10.1 Global Biologics and Biosimilars Market Size Forecast 106
10.2 Global Biologics and Biosimilars Market Forecast by Region 106
10.2.1 North America Market Size Forecast by Country 107
10.2.2 Europe Biologics and Biosimilars Market Size Forecast by Country 108
10.2.3 Asia Pacific Biologics and Biosimilars Market Size Forecast by Region 108
10.2.4 South America Biologics and Biosimilars Market Size Forecast by Country 109
10.2.5 Middle East and Africa Forecasted Consumption of Biologics and Biosimilars by Country 109
11 Forecast Market by Type and by Application (2022-2028) 111
11.1 Global Biologics and Biosimilars Market Forecast by Type (2022-2028) 111
11.1.1 Global Forecasted Sales of Biologics and Biosimilars by Type (2022-2028) 111
11.1.2 Global Biologics and Biosimilars Market Size Forecast by Type (2022-2028) 111
11.1.3 Global Forecasted Price of Biologics and Biosimilars by Type (2022-2028) 112
11.2 Global Biologics and Biosimilars Market Forecast by Application (2022-2028) 112
11.2.1 Global Biologics and Biosimilars Sales (K Units) Forecast by Application 112
11.2.2 Global Biologics and Biosimilars Market Size (M USD) Forecast by Application (2022-2028) 113
12 Conclusion and Key Findings 114

Tables and Figures
Contact Our Sales team for List of Tables & Figures.

Key Players
•Roche
•Amgen
•AbbVie
•Sanofi-Aventis
•Johnson & Johnson
•Pfizer
•Novo Nordisk
•Eli Lilly
•Novartis
•Merck
•3sbio
•Changchun High Tech
•CP Guojian
•Biotech
•Gelgen
•Innovent
•Dong Bao
•Ganlee
•United Laboratories

Speak With Analyst

Name

Corporate Email ID

Country

Phone No.

Your Message

Report Details

Speak With Analyst